Skip to main content
Clinical Trials/NCT07562308
NCT07562308
Not yet recruiting
Not Applicable

Intravenous Dexmedetomidine Vs. Lidocaine for Laryngeal Mask Insertion Conditions In Pediatric Patients Undergoing Elective Surgeries, A Randomized Controlled Trial.

Assiut University1 site in 1 country60 target enrollmentStarted: April 1, 2026Last updated:

Overview

Phase
Not Applicable
Status
Not yet recruiting
Enrollment
60
Locations
1
Primary Endpoint
First-attempt insertion success rate

Overview

Brief Summary

Laryngeal Mask Airways Are Supraglottic Devices Used to Maintain Airway Patency During Anesthesia and in Difficult Airways. LMA may help in reducing postoperative pulmonary complications. IV Dexmedetomidine Improves LMA Insertion Success and Decreases trials number, While IV Lidocaine Decreases Postoperative Cough. This is a randomized interventional trial comparing both drugs. IV DEX will be compared vs IV lidocaine regarding the feasibility of insertion, number of trials, incidence of cough, postoperative pulmonary complications and hemodynamic profile.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Double (Participant, Outcomes Assessor)

Eligibility Criteria

Ages
2 Years to 12 Years (Child)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Parental/guardian consent. Age 2-12 years, ASA physical status I-II. Elective surgery requiring LMA (duration \<2 hours).

Exclusion Criteria

  • Known airway anomalies (e.g., tonsillar hypertrophy, cleft palate). Cardiovascular disease (bradycardia, arrhythmias). Allergy to study drugs. BMI \>95th percentile.

Arms & Interventions

Group (D) DEX

Active Comparator

Dose: 0.2 mcg/kg IV in 10 mL saline, infused over 10 min pre-induction.

Intervention: Dexamedomedine (Drug)

Group (L) Lidocaine

Active Comparator

Dose: 1.5 mg/kg IV (max 100 mg) in 10 ml saline over 1 min before induction.

Intervention: Lidocaine (drug) (Drug)

Outcomes

Primary Outcomes

First-attempt insertion success rate

Time Frame: After induction of anesthesia

The success of the first trial of classic LMA insertion will be assessed. Binary: yes or no.

Secondary Outcomes

  • Ease of insertion (4-point scale)(After Induction of anesthesia)
  • Heart rate(Every 15 minutes till recovery)
  • MAP(Every 15 minutes)
  • Recovery Time(After cessation of anesthesia administration)
  • Postoperative Agitation(In PACU)
  • Postoperative Complications(0,1,2,6 hours postoperative.)
  • PONV(24 hours postoperative)
  • Postoperative sore throat (0-3 scale).(24 hours postoperative)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Abdelrahman Hamdy Mohammed

Lecturer of Anesthesia & ICU, Faculty of Medicine, Assiut University

Assiut University

Study Sites (1)

Loading locations...

Similar Trials